Advertisement
Perspective

Why Open Drug Discovery Needs Four Simple Rules for Licensing Data and Models

  • Antony J. Williams mail,

    tony27587@gmail.com

    Affiliation: Royal Society of Chemistry, Wake Forest, North Carolina, United States of America

    X
  • John Wilbanks,

    Affiliation: Consent to Research, Oakland, California, United States of America

    X
  • Sean Ekins

    Affiliation: Collaborations in Chemistry, Fuquay-Varina, North Carolina, United States of America

    X
  • Published: September 27, 2012
  • DOI: 10.1371/journal.pcbi.1002706

Reader Comments (1)

Post a new comment on this article